# EDGAR Filing Document

**Accession Number:** 0001259993
**File Stem:** 0000045919-25-000046
**Filing Date:** 2025-7
**Character Count:** 6717
**Document Hash:** c536db6bb7f0f781cd1130e1bec2b6c3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000045919-25-000046.hdr.sgml**: 20250703

**ACCESSION NUMBER**: 0000045919-25-000046

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250602

**FILED AS OF DATE**: 20250703

**DATE AS OF CHANGE**: 20250703

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** GARRISON DAVID A
- **CENTRAL INDEX KEY:** 0001259993

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07120
- **FILM NUMBER:** 251104698

**MAIL ADDRESS:**
- **STREET 1:** C/O ARRHYTHMIA RESEARCH TECHNOLOGY INC.
- **STREET 2:** 25 SAWYER PASSWAY
- **CITY:** FITCHBURG
- **STATE:** MA
- **ZIP:** 01420
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HARTE HANKS INC
- **CENTRAL INDEX KEY:** 0000045919
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-DIRECT MAIL ADVERTISING SERVICES [7331]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 741677284
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1 EXECUTIVE DRIVE
- **STREET 2:** SUITE 303
- **CITY:** CHELMSFORD
- **STATE:** MA
- **ZIP:** 01824
- **BUSINESS PHONE:** 5124341100

**MAIL ADDRESS:**
- **STREET 1:** 1 EXECUTIVE DRIVE
- **STREET 2:** SUITE 303
- **CITY:** CHELMSFORD
- **STATE:** MA
- **ZIP:** 01824

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HARTE HANKS COMMUNICATIONS INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HARTE HANKS NEWSPAPERS INC
- **DATE OF NAME CHANGE:** 19771010

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>GARRISON DAVID A<br><sub>(Last) (First) (Middle)</sub><br>1 EXECUTIVE DRIVE SUITE 303<br><sub>(Street)</sub><br>CHELMSFORD, MA 01824<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-02 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>HARTE HANKS INC [ HHS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-06-02 |  | A |  | 25000 | A | $4.55 | 25000<sup>(1)</sup> | I | Held by Harte Hanks until vested |
| Common Stock |  |  |  |  |  |  |  | 13129 | I | Shares held in participant's retirement account.<sup>(2)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Option to buy Common Shares | $7.74 |  |  |  |  |  |  | 2025-01-29<sup>(3)</sup> | 2034-01-29 | Common Stock | 64600<sup>(4)</sup> |  | 64600 | I | NQ stock options granted and held by Harte Hanks, Inc. until exercised. |

---

### Footnotes:

(1) Participant was granted 25,000 RSU shares on 6/02/2025 (contract signed on 7/03/25) which will vest in three equal tranches on the anniversary of the grant date over the following three consecutive years.

(2) Shares were purchased and held in participant's retirement account.

(3) 1/3 of options vests annually on January 29, beginning in 2025 and ending in 2027.

(4) Participant was granted 64,600 NQ stock options on 1/29/2024 that will vest 33% on the first three anniversaries of the grant date, 1/29/2025, 1/29/2026, and 1/29/2027.

**Signature:** /s/ Robert Wyman, Attorney-in-fact for David A Garrison  
**Date:** 2025-07-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**